Found: 12
Select item for more details and to access through your institution.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. 584, doi. 10.1016/j.clgc.2023.06.008
- By:
- Publication type:
- Article
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 4, p. 1, doi. 10.1016/j.clgc.2023.03.015
- By:
- Publication type:
- Article
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 2, p. 286, doi. 10.1016/j.clgc.2022.11.003
- By:
- Publication type:
- Article
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. e440, doi. 10.1016/j.clgc.2022.06.001
- By:
- Publication type:
- Article
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 6, p. 558, doi. 10.1016/j.clgc.2022.08.006
- By:
- Publication type:
- Article
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 139, doi. 10.1016/j.clgc.2021.12.015
- By:
- Publication type:
- Article
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 166, doi. 10.1016/j.clgc.2021.12.012
- By:
- Publication type:
- Article
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 8, p. 1069, doi. 10.3390/biology12081069
- By:
- Publication type:
- Article
Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer.
- Published in:
- BJU International, 2022, v. 130, n. 5, p. 592, doi. 10.1111/bju.15603
- By:
- Publication type:
- Article
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration.
- Published in:
- BJU International, 2021, v. 128, n. 5, p. 607, doi. 10.1111/bju.15434
- By:
- Publication type:
- Article
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
- Published in:
- BJU International, 2021, v. 128, n. 2, p. 196, doi. 10.1111/bju.15324
- By:
- Publication type:
- Article
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article